Cervical Cancer Screening Technologies With Pap And Hpv

Data suggest that cytologic screening for cervical cancer reduces the incidence of cervical cancer by up to 50%. Several technologies have been investigated for their role in detecting cancerous and precancerous cervical lesions. Evidence firmly supports the use of HPV testing for both initial screening in women older than age 30 and in triage of ASCUS results for all women. The use of automated slide reading systems is supported by a small body of evidence that the systems may increase sensitivity <a id="